Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
Frontiers in Cell and Developmental Biology
|
January 3, 2022
PDE4B Induces Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Is Transcriptionally Suppressed by CBX7
Zhengnan Huang, Jiakuan Liu, Jiale Yang, et al.
Scientific Reports
|
March 16, 2016
Targeted disruption of sp7 and myostatin with CRISPR-Cas9 results in severe bone defects and more muscular cells in common carp
Zhaomin Zhong, Pengfei Niu, Mingyong Wang, et al.
BMC Urology
|
January 28, 2023
A prognostic model based on necroptosis-related genes for prognosis and therapy in bladder cancer
Zeyi Wang, Zhengnan Huang, Xiangqian Cao, et al.
Annals of Medicine
|
August 23, 2025
Emotional stress: a prominent factor positively related to the onset and recurrence of bladder cancer as revealed by NHANES and a Chinese database
Wentao Luo, Yifei Chen, Danjing Shen, et al.
Gene
|
April 27, 2007
Conserved function of caspase-8 in apoptosis during bony fish evolution
Shin-ichi Sakata, Yilin Yan, Yutaka Satou, et al.
Frontiers in Genetics
|
January 23, 2023
A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer
Jinming Cai, Haoran Xie, Yilin Yan, et al.
International Journal of Nanomedicine
|
December 11, 2023
Promoting Intratumoral Drug Accumulation by Bio-Membrane Regulated Active Targeting for Tumor Photothermal Therapy
Chenkai Yang, Xiangqian Cao, Lei He, et al.
Free Radical Biology & Medicine
|
December 30, 2023
Lactoferrin ameliorated obesity-induced endothelial dysfunction by inhibiting the Tak1/IL-18/eNOS pathway between PVAT and vascular endothelium
Cailong Chen, Yilin Yan, Yunxuan Wu, et al.
Cell Death & Disease
|
May 26, 2021
CBX7 suppresses urinary bladder cancer progression via modulating AKR1B10-ERK signaling
Zhengnan Huang, Yilin Yan, Zhen Zhu, et al.
Gynecologic Oncology
|
September 19, 2025
Sacituzumab govitecan in Chinese patients with recurrent/metastatic cervical cancer: Results from the phase 2 EVER-132-003 basket study (NCT05119907)
Jusheng An, Guiling Li, Yunyan Zhang, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
Frontiers in Cell and Developmental Biology
|
January 3, 2022
PDE4B Induces Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Is Transcriptionally Suppressed by CBX7
Zhengnan Huang, Jiakuan Liu, Jiale Yang, et al.
Scientific Reports
|
March 16, 2016
Targeted disruption of sp7 and myostatin with CRISPR-Cas9 results in severe bone defects and more muscular cells in common carp
Zhaomin Zhong, Pengfei Niu, Mingyong Wang, et al.
BMC Urology
|
January 28, 2023
A prognostic model based on necroptosis-related genes for prognosis and therapy in bladder cancer
Zeyi Wang, Zhengnan Huang, Xiangqian Cao, et al.
Annals of Medicine
|
August 23, 2025
Emotional stress: a prominent factor positively related to the onset and recurrence of bladder cancer as revealed by NHANES and a Chinese database
Wentao Luo, Yifei Chen, Danjing Shen, et al.
Gene
|
April 27, 2007
Conserved function of caspase-8 in apoptosis during bony fish evolution
Shin-ichi Sakata, Yilin Yan, Yutaka Satou, et al.
Frontiers in Genetics
|
January 23, 2023
A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer
Jinming Cai, Haoran Xie, Yilin Yan, et al.
International Journal of Nanomedicine
|
December 11, 2023
Promoting Intratumoral Drug Accumulation by Bio-Membrane Regulated Active Targeting for Tumor Photothermal Therapy
Chenkai Yang, Xiangqian Cao, Lei He, et al.
Free Radical Biology & Medicine
|
December 30, 2023
Lactoferrin ameliorated obesity-induced endothelial dysfunction by inhibiting the Tak1/IL-18/eNOS pathway between PVAT and vascular endothelium
Cailong Chen, Yilin Yan, Yunxuan Wu, et al.
Cell Death & Disease
|
May 26, 2021
CBX7 suppresses urinary bladder cancer progression via modulating AKR1B10-ERK signaling
Zhengnan Huang, Yilin Yan, Zhen Zhu, et al.
Gynecologic Oncology
|
September 19, 2025
Sacituzumab govitecan in Chinese patients with recurrent/metastatic cervical cancer: Results from the phase 2 EVER-132-003 basket study (NCT05119907)
Jusheng An, Guiling Li, Yunyan Zhang, et al.
Page
of 6